Budget Impact and Incremental Survival Benefit of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Brazil
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2211
https://www.valueinhealthjournal.com/article/S1098-3015(14)04141-2/fulltext
Title :
Budget Impact and Incremental Survival Benefit of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04141-2&doi=10.1016/j.jval.2014.08.2211
First page :
A623
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1673